CAR-T Disease Outlook [2017]PharmiWeb.com (press release)Anti-CD19 CAR-T cell therapies have demonstrated unprecedented response rates across patient subgroups of acute lymphocytic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) with high unmet needs. … Continue reading
Technology Networks |
Microfluidics for the Masses
Technology Networks “There’s been quite a bit of sharing of different types of information around synthetic biology,” Kong observes. “So this kind of larger open-source movement in biotech is important, and we’re hoping to fill this key part of the ecosystem that’s … |
|
DuPont Pioneer Secures Exclusive Rights To ERS Genomics’ CRISPR-Cas Patent Portfolio For Agriculture
Chemical Online.com (press release) The licensing agreement with ERS complements DuPont’s previously announced CRISPR-Cas licensing and collaboration agreements with Caribou Biosciences and Vilnius University. Johnston, IOWA (PRWEB) DuPont Pioneer (DuPont) and ERS Genomics … |
Technology Networks |
Treating Asthma with Stem Cells
Technology Networks The Monash Biomedicine Discovery Institute (BDI) scientists provided the experimental expertise to test Cynata Therapeutics’ induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) in a model of experimental asthma. Induced pluripotent stem … |